A homozygous frameshift variant expands the clinical spectrum of SAMD9 gene defects

Abstract SAMD9, a ubiquitously expressed protein, is involved in several mechanisms, including endosome fusion, growth suppression and modulation of innate immune responses to stress and viral infections. While biallelic mutations in SAMD9 are linked to normophosphatemic familial tumoral calcinosis, heterozygous gain‐of‐function mutations in the same gene are responsible for MIRAGE, a multisystemic syndrome characterized by m yelodysplasia, i nfection, r estriction of growth, a drenal hypoplasia, g enital phenotypes, and e nteropathy. A two‐and‐a‐half‐year‐old girl, from a consanguineous Lebanese family, was included in this study. She presents with pre‐ and post‐natal growth retardation, recurrent fevers, persistent diarrhea, elevated CRP and intermittent hypoglycemia. Whole genome sequencing revealed a homozygous frameshift variant in SAMD9 (NM_017654.4: c.480_481del; p.Val162Ilefs*5) in the proband. Sanger sequencing confirms its segregation with the disease in the family, and immunoblotting showed that the detected variant abolishes SAMD9 expression in the patient. Our findings expand the clinical spectrum linked to SAMD9 and highlight the importance of investigating further cases with mutations in this gene, as this will pave the way towards the understanding of the pathways driving these diseases.